当前位置: X-MOL 学术J. Refract. Surg. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Relifting Flap Enhancement Procedure After Primary Allogenic Refractive Lenticule Implantation.
Journal of Refractive Surgery ( IF 2.4 ) Pub Date : 2021-10-01 , DOI: 10.3928/1081597x-20210712-06
Jiawei Wu , Lu Xiong , Zheng Wang

PURPOSE To describe the results of a relifting flap enhancement procedure for correction of residual refractive error after primary lenticule intrastromal keratoplasty (LIKE). METHODS Case report. RESULTS One year after a LIKE procedure in the left eye, the patient (uncorrected distance visual acuity [UDVA]: 20/25; corrected distance visual acuity [CDVA]: 20/20; manifest refraction: -1.00 +1.00 × 105°) underwent flap relifting. The WaveLight EX500 excimer laser platform (Alcon Laboratories, Inc) was used for the topography-guided enhancement procedure to correct the residual refractive error and corneal irregularities. During the 1-year follow-up period, the cornea remained clear, the UDVA increased to 20/20 (reaching the level of preoperative CDVA), and manifest refraction was -0.25 +0.75 × 90°. CONCLUSIONS The enhancement procedure described in this case report was effective for correction of residual refractive error and improvement of visual acuity following the LIKE procedure. The enhancement was stable for at least 15 months after the procedure. [J Refract Surg. 2021;37(10):715-719.].

中文翻译:

初次同种异体屈光性微透镜植入后的提升皮瓣增强程序。

目的 描述用于矫正初级微透镜基质内角膜移植术 (LIKE) 后残余屈光不正的再提皮瓣增强手术的结果。方法 病例报告。结果 左眼 LIKE 手术一年后,患者(未矫正远视力 [UDVA]:20/25;矫正远视力 [CDVA]:20/20;明显屈光度:-1.00 +1.00 × 105°)接受了皮瓣复位。WaveLight EX500 准分子激光平台(Alcon Laboratories, Inc)用于地形引导的增强程序,以校正残余屈光不正和角膜不规则。随访1年,角膜保持清晰,UDVA增至20/20(达到术前CDVA水平),明显屈光度为-0.25+0.75×90°。结论 本病例报告中描述的增强程序对于矫正残余屈光不正和 LIKE 程序后视力的改善是有效的。增强在手术后至少稳定 15 个月。[J 屈光手术。2021;37(10):715-719.]。
更新日期:2021-10-01
down
wechat
bug